Jamie Mark Grooms is Director at AxoGen, Inc. (AXGN). They have made 5 open-market trades across 1 company since 2017, most recently 2018-09-20.
CIK 0001530935
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AXGN | SELL | 2018-02-21 | 2018-02-23 | $28.40 | $3.3M | +19.2% | +39.0% | +57.2% |
| AXGN | SELL | 2018-02-16 | 2018-02-20 | $27.57 | $2.5M | +18.3% | +42.0% | +57.6% |
| AXGN | SELL | 2018-02-13 | 2018-02-16 | $26.88 | $4.9M | +25.3% | +39.7% | +56.6% |
| AXGN | SELL | 2017-12-11 | 2017-12-13 | $26.34 | $1.4M | +5.1% | +4.9% | +31.6% |
| AXGN | SELL | 2017-12-06 | 2017-12-13 | $26.35 | $3.7M | +5.1% | +4.9% | +31.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.